2-108470358-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_181453.4(GCC2):āc.1029A>Gā(p.Glu343Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00597 in 1,605,726 control chromosomes in the GnomAD database, including 59 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0044 ( 4 hom., cov: 33)
Exomes š: 0.0061 ( 55 hom. )
Consequence
GCC2
NM_181453.4 synonymous
NM_181453.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.667
Genes affected
GCC2 (HGNC:23218): (GRIP and coiled-coil domain containing 2) The protein encoded by this gene is a peripheral membrane protein localized to the trans-Golgi network. It is sensitive to brefeldin A. This encoded protein contains a GRIP domain which is thought to be used in targeting. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 2-108470358-A-G is Benign according to our data. Variant chr2-108470358-A-G is described in ClinVar as [Benign]. Clinvar id is 774289.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.667 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. gnomad4_exome allele frequency = 0.00613 (8914/1453386) while in subpopulation EAS AF= 0.0203 (803/39580). AF 95% confidence interval is 0.0191. There are 55 homozygotes in gnomad4_exome. There are 4516 alleles in male gnomad4_exome subpopulation. Median coverage is 29. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GCC2 | NM_181453.4 | c.1029A>G | p.Glu343Glu | synonymous_variant | 6/23 | ENST00000309863.11 | NP_852118.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GCC2 | ENST00000309863.11 | c.1029A>G | p.Glu343Glu | synonymous_variant | 6/23 | 5 | NM_181453.4 | ENSP00000307939.5 |
Frequencies
GnomAD3 genomes AF: 0.00440 AC: 670AN: 152222Hom.: 4 Cov.: 33
GnomAD3 genomes
AF:
AC:
670
AN:
152222
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00599 AC: 1464AN: 244580Hom.: 11 AF XY: 0.00611 AC XY: 809AN XY: 132330
GnomAD3 exomes
AF:
AC:
1464
AN:
244580
Hom.:
AF XY:
AC XY:
809
AN XY:
132330
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00613 AC: 8914AN: 1453386Hom.: 55 Cov.: 29 AF XY: 0.00625 AC XY: 4516AN XY: 723114
GnomAD4 exome
AF:
AC:
8914
AN:
1453386
Hom.:
Cov.:
29
AF XY:
AC XY:
4516
AN XY:
723114
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00441 AC: 672AN: 152340Hom.: 4 Cov.: 33 AF XY: 0.00458 AC XY: 341AN XY: 74506
GnomAD4 genome
AF:
AC:
672
AN:
152340
Hom.:
Cov.:
33
AF XY:
AC XY:
341
AN XY:
74506
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
49
AN:
3474
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 21, 2018 | - - |
GCC2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 21, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at